Search

Your search keyword '"Adrian Gologan"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Adrian Gologan" Remove constraint Author: "Adrian Gologan"
32 results on '"Adrian Gologan"'

Search Results

1. Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer

2. Autistic Enterocolitis: Fact or Fiction?

3. Rituximab-induced autoimmune hepatitis: A case study and literature review

4. Is the Pathologic Response of T3 Rectal Cancer to High-Dose-Rate Endorectal Brachytherapy Comparable to External Beam Radiotherapy?

5. Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer

6. Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?

7. Characterization of a novel founderMSH6mutation causing Lynch syndrome in the French Canadian population

8. Characterizations of DNA copy number variations and spatio-temporal intra tumor heterogeneity in liver metastasis from colorectal cancer patients

9. Copy number variation in longitudinal liver metastases biopsies in colorectal cancer identifies biomarker candidates of resistance to standard chemotherapy

10. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine

11. EP-1291: Can mucosal criteria estimate response in rectal cancer treated with neoadjuvant chemoradiotherapy?

12. Abstract LB-231: Genomic profiling in serial metastatic colorectal tumors identifies copy number alterations and spatio temporal intra-patient heterogeneity profiles associated with clinical response. Q-CROC-01: NCT00984048

13. High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families

14. Somatic Mosaicism of Androgen Receptor CAG Repeats in Colorectal Carcinoma Epithelial Cells From Men

15. Underexpression of Mineralocorticoid Receptor in Colorectal Carcinomas and Association with VEGFR-2 Overexpression

16. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype

17. Age-Associated Changes in Alpha-Methyl CoA Racemase (AMACR) Expression in Nonneoplastic Prostatic Tissues

18. Molecular Markers in Helicobacter pylori-Associated Gastric Carcinogenesis

19. Malignant Fibrous Histiocytoma, Giant Cell Type, of the Breast Mimicking Metaplastic Carcinoma

20. Abstract 2795: Integrating multiomics discovery approaches to identify biomarkers of therapeutic resistance in metastatic colorectal cancer through analyses of multiple sequential tumor and liquid biopsies; Qcroc01: NCT00984048

21. EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

22. Autistic enterocolitis: Fact or fiction?

23. Polymeric immunoglobulin receptor-negative tumors represent a more aggressive type of adenocarcinomas of distal esophagus and gastroesophageal junction

24. Can Clinical Criteria Estimate Pathological Complete Response in Rectal Cancer Treated With Neoadjuvant High Dose Rate Brachytherapy?

25. Abstract 3888: Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048)

26. P-306 A phase II biopsy-driven study to identify biomarkers predictive of clinical response to second-line regorafenib in patients with metastatic colorectal cancer

27. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability

28. Malignant fibrous histiocytoma, giant cell type, of the breast mimicking metaplastic carcinoma. A case report

29. Biopsy-driven study to identify biomarkers predictive of clinical response to second-line regorafenib in patients with metastatic colorectal cancer

30. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness

31. MC13-0077 Array CGH analysis of paired metastatic biopsies obtained pre-treatment and at resistance to FOLFOX-bevacizumab in metastatic CRC patients

32. EGFR expression in invasive anal carcinoma

Catalog

Books, media, physical & digital resources